Celina Abi Khalil joined the Wyss Center in September 2023 as Senior Regulatory Affairs Specialist and was promoted to Regulatory & Clinical Affairs Manager in January 2024. In this role, she leads the Regulatory and Clinical Affairs activities related to the development of various medical device technologies for neurological applications. Her responsibilities include shaping the regulatory strategy, ensuring smooth technical and regulatory communication among all project stakeholders, and nurturing strong collaboration with quality, clinical, design, and development teams.

Celina studied life sciences and obtained a PhD from University of Montpellier in France before pursuing a career in clinical and regulatory affairs in the medical device industry. Celina worked on class, I, II and III implantable products as well as Software as a Medical Device and electro-medical devices. She also worked on the transition from the MDD 93/42/CEE directive to MDR 2017/745 and defined the regulatory strategy for the product development within the European and American normative framework. She also coordinated access to market in different areas including Eu, U.S., Asia, and Latin America.